James Chih‐Hsin Yang
- Oncology top 0.01%
- Pulmonary and Respiratory Medicine top 0.01%
- Molecular Biology top 0.1%
- Immunology top 0.02%
- Cancer Research top 0.02%
- Co-authors
- Steven A. RosenbergRichard M. SherrySuzanne L. TopalianDonald E. WhiteTony MokDouglas J. SchwartzentruberSeth M. SteinbergNicholas P. Restifo
- Topics
- Lung Cancer Treatments and Mutations (480 papers)Lung Cancer Research Studies (204 papers)Colorectal Cancer Treatments and Studies (175 papers)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
James Chih‐Hsin Yang
679 papers receiving 65.0k citations
Hit Papers
Peers
Comparison fields: 5 of 181
- Oncology 46.1k
- Pulmonary and Respiratory Medicine 33.9k
- Molecular Biology 18.4k
- Immunology 18.0k
- Cancer Research 9.4k
Countries citing papers authored by James Chih‐Hsin Yang
This map shows the geographic impact of James Chih‐Hsin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Chih‐Hsin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Chih‐Hsin Yang more than expected).
Fields of papers citing papers by James Chih‐Hsin Yang
This network shows the impact of papers produced by James Chih‐Hsin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Chih‐Hsin Yang. The network helps show where James Chih‐Hsin Yang may publish in the future.
Co-authorship network of co-authors of James Chih‐Hsin Yang
This figure shows the co-authorship network connecting the top 25 collaborators of James Chih‐Hsin Yang. A scholar is included among the top collaborators of James Chih‐Hsin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Chih‐Hsin Yang. James Chih‐Hsin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 50 | |
| 3 | 72 | |
| 4 | 31 | |
| 5 | Short-Term Clinical and Oncological Outcome of Prolonging Operation Interval After Neoadjuvant Chemoradiotherapy for Locally Advanced Middle and Low Rectal Cancer | 2 |
| 6 | 204 | |
| 7 | Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activitybreakdown → | 523 |
| 8 | Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cellsbreakdown → | 506 |
| 9 | A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Responsebreakdown → | 585 |
| 10 | 44 | |
| 11 | Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutationsbreakdown → | 2461 |
| 12 | 369 | |
| 13 | Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancerbreakdown → | 429 |
| 14 | 54 | |
| 15 | Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapybreakdown → | 1603 |
| 16 | 361 | |
| 17 | Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimensbreakdown → | 1017 |
| 18 | Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytesbreakdown → | 1961 |
| 19 | Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4breakdown → | 646 |
| 20 | Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanomabreakdown → | 1234 |
About James Chih‐Hsin Yang
James Chih‐Hsin Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 698 papers that have together received 66.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (480 papers), Lung Cancer Research Studies (204 papers) and Colorectal Cancer Treatments and Studies (175 papers). The work is most often cited by research in Oncology (46.1k citations), Pulmonary and Respiratory Medicine (33.9k citations) and Immunology (18.0k citations). James Chih‐Hsin Yang has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Steven A. Rosenberg, Richard M. Sherry, Suzanne L. Topalian, Donald E. White, Tony Mok, Douglas J. Schwartzentruber, Seth M. Steinberg, Nicholas P. Restifo, Udai S. Kammula and Claudia A. Seipp. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.